A matter of dosage

被引:98
作者
Fodde, R [1 ]
Smits, R [1 ]
机构
[1] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands
关键词
D O I
10.1126/science.1077707
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
18
引用
收藏
页码:761 / 763
页数:3
相关论文
共 19 条
[1]   The murine gene p27Kip1 is haplo-insufficient for tumour suppression [J].
Fero, ML ;
Randel, E ;
Gurley, KE ;
Roberts, JM ;
Kemp, CJ .
NATURE, 1998, 396 (6707) :177-180
[2]   Enhanced tumor formation in mice heterozygous for Blm mutation [J].
Goss, KH ;
Risinger, MA ;
Kordich, JJ ;
Sanz, MM ;
Straughen, JE ;
Slovek, LE ;
Capobianco, AJ ;
German, J ;
Boivin, GP ;
Groden, J .
SCIENCE, 2002, 297 (5589) :2051-2053
[3]   BLM heterozygosity and the risk of colorectal cancer [J].
Gruber, SB ;
Ellis, NA ;
Rennert, G ;
Offit, K .
SCIENCE, 2002, 297 (5589) :2013-2013
[4]   Biallelic inactivation of BRCA2 in Fanconi anemia [J].
Howlett, NG ;
Taniguchi, T ;
Olson, S ;
Cox, B ;
Waisfisz, Q ;
de Die-Smulders, C ;
Persky, N ;
Grompe, M ;
Joenje, H ;
Pals, G ;
Ikeda, H ;
Fox, EA ;
D'Andrea, AD .
SCIENCE, 2002, 297 (5581) :606-609
[5]   Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas [J].
Inoue, K ;
Zindy, F ;
Randle, DH ;
Rehg, JE ;
Sherr, CJ .
GENES & DEVELOPMENT, 2001, 15 (22) :2934-2939
[7]   Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression [J].
Kucherlapati, M ;
Yan, K ;
Kuraguchi, M ;
Zhao, J ;
Lia, M ;
Heyer, J ;
Kane, MF ;
Fan, KH ;
Russell, R ;
Brown, AMC ;
Kneitz, B ;
Edelmann, W ;
Kolodner, RD ;
Lipkin, M ;
Kucherlapati, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) :9924-9929
[8]   Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression [J].
Kwabi-Addo, B ;
Giri, D ;
Schmidt, K ;
Podsypanina, K ;
Parsons, R ;
Greenberg, N ;
Ittmann, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :11563-11568
[9]   Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations [J].
Meijers-Heijboer, H ;
van den Ouweland, A ;
Klijn, J ;
Wasielewski, M ;
de Snoo, A ;
Oldenburg, R ;
Hollestelle, A ;
Houben, M ;
Crepin, E ;
van Veghel-Plandsoen, M ;
Elstrodt, F ;
van Duijn, C ;
Bartels, C ;
Meijers, C ;
Schutte, M ;
McGuffog, L ;
Thompson, D ;
Easton, DF ;
Sodha, N ;
Seal, S ;
Barfoot, R ;
Mangion, J ;
Chang-Claude, J ;
Eccles, D ;
Eeles, R ;
Evans, DG ;
Houlston, R ;
Murday, V ;
Narod, S ;
Peretz, T ;
Peto, J ;
Phelan, C ;
Zhang, HX ;
Szabo, C ;
Devilee, P ;
Goldgar, D ;
Futreal, PA ;
Nathanson, KL ;
Weber, BL ;
Rahman, N ;
Stratton, MR .
NATURE GENETICS, 2002, 31 (01) :55-59
[10]  
Miyoshi H, 2002, CANCER RES, V62, P2261